- Home
- / EASTON BIOPHARMACEUTICALS
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
EASTON BIOPHARMACEUTICALS financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥34.8
2024-10-29
Market Capitalization
¥6.1 B
2024-10-29
Revenue
¥1.3 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 14, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 755.9M | 928.0M | 907.4M | 1.0B | 1.2B | 1.1B | 1.3B | 1.3B |
| Cost of goods sold | 87.4M | 92.3M | 105.0M | 143.3M | 196.0M | 223.3M | 338.4M | 329.5M |
| Gross profit | 669.3M | 840.3M | 802.9M | 863.9M | 956.4M | 876.0M | 990.3M | 982.1M |
| Gross profit margin, % | 88.5% | 90.5% | 88.5% | 85.8% | 83.0% | 79.8% | 74.6% | 75.0% |
| Operating expense total | 554.7M | 751.8M | 646.6M | 695.7M | 737.4M | 648.8M | 732.4M | 689.6M |
| Depreciation and amortization | 25.4M | 27.5M | 33.4M | 33.0M | 58.3M | 73.2M | 83.0M | 92.8M |
| EBITDA | 114.6M | 88.5M | 156.2M | 168.2M | 219.5M | 227.3M | 256.5M | 292.1M |
| EBITDA margin, % | 15.2% | 9.5% | 17.2% | 16.7% | 19.1% | 20.7% | 19.3% | 22.3% |
| EBIT | 143.2M | 107.6M | 186.4M | 214.6M | 243.9M | 219.6M | 228.4M | 250.6M |
| EBIT margin, % | 19.0% | 11.6% | 20.5% | 21.3% | 21.2% | 20.0% | 17.2% | 19.1% |
| Interest income | 2.3M | 1.4M | 3.7M | 4.5M | 12.8M | 14.7M | 17.5M | 13.1M |
| Interest expense | 724.0K | 364.0K | 2.6M | 3.4M | 3.7M | 2.5M | ||
| Pre tax profit | 148.3M | 115.9M | 199.1M | 246.9M | 262.0M | 241.6M | 252.6M | 299.7M |
| Income tax expense | 13.3M | 7.3M | 20.9M | 14.5M | 15.5M | 15.1M | 14.4M | 26.1M |
| Net Income | 135.0M | 108.6M | 178.2M | 232.4M | 246.5M | 226.6M | 238.2M | 273.6M |